Similarly to TEPP-46, DASA-58 inhibits HCC proliferation and mitigates the progression of hepatic inflammatory diseases by maintaining PKM2 in its tetrameric state [107,108]. This evidence concerns the gene PKM and hepatocellular carcinoma.